Beech Hill Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.68M | Buy |
69,581
+385
| +0.6% | +$10.1K | 0.74% | 50 |
|
|
2026
Q1 | $1.94M | Sell |
69,196
-1,431
| -2% | -$38.1K | 0.97% | 45 |
|
|
2025
Q4 | $1.76M | Sell |
70,627
-830
| -1% | -$20.9K | 0.84% | 51 |
|
|
2025
Q3 | $1.82M | Buy |
71,457
+2,319
| +3% | +$57.2K | 0.85% | 50 |
|
|
2025
Q2 | $1.68M | Sell |
69,138
-9,776
| -12% | -$228K | 0.75% | 54 |
|
|
2025
Q1 | $2M | Sell |
78,914
-2,210
| -3% | -$57.8K | 0.8% | 52 |
|
|
2024
Q4 | $2.15M | Sell |
81,124
-26,454
| -25% | -$718K | 0.81% | 47 |
|
|
2024
Q3 | $3.11M | Buy |
107,578
+4,790
| +5% | +$140K | 1.18% | 33 |
|
|
2024
Q2 | $2.88M | Sell |
102,788
-3,290
| -3% | -$90.6K | 1.19% | 33 |
|
|
2024
Q1 | $2.94M | Buy |
106,078
+8,256
| +8% | +$229K | 1.22% | 34 |
|
|
2023
Q4 | $2.82M | Buy |
97,822
+1,791
| +2% | +$54.1K | 1.36% | 31 |
|
|
2023
Q3 | $3.19M | Buy |
96,031
+8,015
| +9% | +$283K | 1.61% | 27 |
|
|
2023
Q2 | $3.23M | Buy |
88,016
+2,365
| +3% | +$92.1K | 1.57% | 28 |
|
|
2023
Q1 | $3.49M | Buy |
85,651
+605
| +0.7% | +$26.1K | 1.76% | 23 |
|
|
2022
Q4 | $4.36M | Sell |
85,046
-1,875
| -2% | -$89.9K | 2.42% | 12 |
|
|
2022
Q3 | $3.8M | Sell |
86,921
-275
| -0.3% | -$13.4K | 2.18% | 15 |
|
|
2022
Q2 | $4.57M | Sell |
87,196
-2,723
| -3% | -$139K | 2.44% | 8 |
|
|
2022
Q1 | $4.66M | Sell |
89,919
-1,405
| -2% | -$72.9K | 1.9% | 15 |
|
|
2021
Q4 | $5.39M | Buy |
91,324
+230
| +0.3% | +$11.4K | 2.05% | 15 |
|
|
2021
Q3 | $3.92M | Sell |
91,094
-38,063
| -29% | -$1.69M | 1.63% | 21 |
|
|
2021
Q2 | $5.06M | Sell |
129,157
-12,099
| -9% | -$471K | 2.05% | 14 |
|
|
2021
Q1 | $5.12M | Buy |
141,256
+1,656
| +1% | +$58.8K | 2.12% | 16 |
|
|
2020
Q4 | $5.14M | Sell |
139,600
-9,225
| -6% | -$338K | 2.28% | 15 |
|
|
2020
Q3 | $5.18M | Buy |
148,825
+4,140
| +3% | +$145K | 2.56% | 13 |
|
|
2020
Q2 | $4.49M | Buy |
144,685
+2,978
| +2% | +$101K | 2.28% | 14 |
|
|
2020
Q1 | $4.39M | Buy |
141,707
+2,919
| +2% | +$99.5K | 3% | 11 |
|
|
2019
Q4 | $5.16M | Buy |
138,788
+1,518
| +1% | +$54.1K | 2.4% | 18 |
|
|
2019
Q3 | $4.68M | Sell |
137,270
-425
| -0.3% | -$15.5K | 2.5% | 15 |
|
|
2019
Q2 | $5.66M | Buy |
137,695
+11,041
| +9% | +$438K | 2.97% | 10 |
|
|
2019
Q1 | $5.1M | Sell |
126,654
-2,240
| -2% | -$89.7K | 3.15% | 10 |
|
|
2018
Q4 | $5.34M | Sell |
128,894
-4,637
| -3% | -$192K | 3.32% | 7 |
|
|
2018
Q3 | $5.58M | Buy |
133,531
+1,345
| +1% | +$51.8K | 2.9% | 8 |
|
|
2018
Q2 | $4.55M | Sell |
132,186
-7,593
| -5% | -$259K | 2.55% | 15 |
|
|
2018
Q1 | $4.71M | Buy |
139,779
+6,455
| +5% | +$222K | 2.48% | 19 |
|
|
2017
Q4 | $4.58M | Buy |
133,324
+880
| +0.7% | +$30K | 2.26% | 16 |
|
|
2017
Q3 | $4.49M | Buy |
132,444
+317
| +0.2% | +$10.2K | 2.37% | 18 |
|
|
2017
Q2 | $4.21M | Buy |
132,127
+91
| +0.1% | +$2.87K | 2.3% | 19 |
|
|
2017
Q1 | $4.29M | Buy |
132,036
+21
| +0% | +$662 | 2.47% | 15 |
|
|
2016
Q4 | $4.07M | Sell |
132,015
-45,997
| -26% | -$1.4M | 2.43% | 17 |
|
|
2016
Q3 | $5.72M | Buy |
178,012
+3,257
| +2% | +$109K | 3.5% | 3 |
|
|
2016
Q2 | $5.84M | Buy |
174,755
+87
| +0% | +$2.78K | 3.95% | 5 |
|
|
2016
Q1 | $4.91M | Buy |
174,668
+2,734
| +2% | +$78.1K | 3.84% | 8 |
|
|
2015
Q4 | $5.27M | Sell |
171,934
-6,427
| -4% | -$202K | 3.33% | 6 |
|
|
2015
Q3 | $5.32M | Sell |
178,361
-792
| -0.4% | -$25.4K | 3.39% | 5 |
|
|
2015
Q2 | $5.7M | Sell |
179,153
-20,254
| -10% | -$660K | 2.93% | 7 |
|
|
2015
Q1 | $6.58M | Buy |
199,407
+17,284
| +9% | +$550K | 3.09% | 6 |
|
|
2014
Q4 | $5.38M | Buy |
182,123
+5,006
| +3% | +$144K | 2.68% | 13 |
|
|
2014
Q3 | $4.97M | Buy |
177,117
+8,335
| +5% | +$234K | 2.35% | 14 |
|
|
2014
Q2 | $4.75M | Buy |
168,782
+9,152
| +6% | +$261K | 2.09% | 18 |
|
|
2014
Q1 | $4.87M | Buy |
159,630
+3,886
| +2% | +$116K | 2.28% | 13 |
|
|
2013
Q4 | $4.53M | Sell |
155,744
-2,684
| -2% | -$78.1K | 2.28% | 15 |
|
|
2013
Q3 | $4.32M | Buy |
158,428
+464
| +0.3% | +$12.6K | 2.34% | 12 |
|
|
2013
Q2 | $4.2M | Buy |
+157,964
| New | +$4.36M | 2.38% | 13 |
|
Other funds holding PFE
AIM
SLAM
CWP
Beech Hill Advisors's PFE Position: Q2 2026 in Review
Beech Hill Advisors increased its Pfizer (PFE) stake by 0.56% in Q2 2026, buying an estimated $10.1K and bringing the position to 69,581 shares worth $1.68M. The position accounts for 0.74% of the portfolio, ranked #50.
Beech Hill Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.58M in Q1 2015. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Beech Hill Advisors held 69,581 shares of Pfizer worth $1.68M as of Q2 2026.
- Beech Hill Advisors bought 385 Pfizer shares in Q2 2026, an estimated $10.1K.
- Pfizer made up 0.74% of Beech Hill Advisors's portfolio in Q2 2026, its #50 holding.
- Beech Hill Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Beech Hill Advisors's Pfizer position peaked at $6.58M in Q1 2015.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Beech Hill Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.